Beijing-based biotech unicorn METiS TechBio has rolled out what it calls the world's first AI-powered nano-delivery platform, ...

In the latest trading session, Moderna (MRNA) closed at $25.51, marking a +2.03% move from the previous day. This change outpaced the S&P 500's 0.48% gain on the day. On the other hand, the Dow ...

Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...

Kirsten E. Lyke, M.D., serves as professor of medicine and director of Vector-borne Diseases and Challenge Unit at the University of Maryland, School of Medicine in Baltimore.

The business of vaccines is getting even more difficult. The world’s market for vaccines, as it exists today, depends on the ...

The Company plans to use the proceeds to accelerate the development of Teverelix, a next generation GnRH Antagonist, as a ...

The advent of more capable artificial intelligence is taking one of the industry’s most prominent investors in new directions.

Cuts to mRNA vaccine funding in the US have stalled infectious disease programmes, with experts warning the consequences are ...